Facial Fillers @ CHP

Facial Fillers Defined
Restylane®, Sculptra® and Aquamid® are three examples of the newest technology in wrinkle treatments and facial enhancement without surgery.

Restylane® (temporary filler)
This Hyaluronic Acid-based ("H.A.") derma fillers can be injected into the laugh lines (labial nasal fold) that stretch from your nose to the side of your mouth. Fillers are also used to increase the volume of your lips, giving a more healthy and vital appearance. One of the main benefits of Hyaluronic Acid injections is that they carry no risk of possible patient allergic rejection.

Sculptra® (semi-permanent filler)
Semi-permanent soft tissue fillers are good options for patients who have already experienced temporary treatments and are ready for more long-term effects. They can sometimes have more significant side effects and results that, while longer lasting, also take longer to become noticeable.

Aquamid® (permanent filler)
The non-absorbable (non-biodegradable) filler that is also non-allergenic is the best for patients looking for a permanent solution to increasing the volume of the lips and nasal fold.

Facial Filler Risks
Unlike collagen injections, these second and third generation fillers are not based on animal extracts and have no risk of allergic reactions. Patients that are not candidates for fillers are those with recurrent herpes (cold sores), active herpes (cold sores), insulin-dependent diabetics (type 1), pregnancy, and many other systemic diseases, as well as those that are on anti-coagulants.

Facial Filler Facts

• Hyaluranic acid-based soft tissue fillers were the fifth most popular non-surgical cosmetic procedure in the United States in 2004. Nearly 900,000 treatments were performed.
• The majority of patients receiving soft tissue fillers in 2004 were between the ages of 35 and 50.
• There were nearly 100,000 autologous fat transfer soft tissue operations performed in 2004.
• When combined, collagen and hyaluronic acid procedures amounted to 14% of all plastic surgery procedures in the United States in 2004.

Request more info or schedule a consultation!



Read about VASER 2.0 >